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ABSTRACT 
Introduction: Children with Down syndrome (DS) experience congenital and functional 
medical issues that predispose them to obstructive sleep apnea (OSA). Research utilizing 
stringent age criteria among samples of infants with DS and OSA is limited. This study examines 
clinical correlates of OSA among infants with DS.  
 
Materials and Methods: A retrospective chart review was conducted of infants ≤6 months of 
age referred to a DS clinic at a tertiary children’s hospital over five-years (n=177). Chi-square 
tests and binary logistic regression models were utilized to analyze the data.  
 
Results: Fifty-nine infants underwent polysomnography, based on clinical concerns. Of these, 
95% (56/59) had studies consistent with OSA. Among infants with OSA, 71% were identified as 
having severe OSA (40/56). The minimum overall prevalence of OSA among the larger group of 
infants was 31% (56/177). Significant relationships were found between OSA and dysphagia, 
congenital heart disease (CHD), prematurity, gastroesophageal reflux disease (GERD), and other 
functional and anatomic gastrointestinal (GI) conditions. Results indicate that odds of OSA in 
this group are higher among infants with GI conditions in comparison to those without. Co-
occurring dysphagia and CHD predicted the occurrence of OSA in 36% of cases with an overall 
predictive accuracy rate of 71%.  
 
Discussion: Obstructive sleep apnea is relatively common in young infants with DS and often 
severe. Medical factors including GI conditions, dysphagia and CHD may help to identify infants 
who are at greater risk and may warrant evaluation. Further studies are needed to assess the 
impact of OSA in infants with DS. 
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INTRODUCTION 
 Down syndrome (DS), caused by a trisomy of all or part of human chromosome 21, is the 
most common chromosomal aneuploidy, and occurs in approximately 1 in 800 live births [Mai et 
al., 2013]. Individuals with DS experience high rates of congenital cardiac, gastrointestinal (GI), 
respiratory, sensory, orthopedic and oropharyngeal complications [Breslin et al., 2014; Cleves et 
al., 2007]. Children with DS also experience increased sleep disturbances [Stores and Stores, 
2013]. Sleep-disordered breathing (SDB), particularly obstructive sleep apnea (OSA), has gained 
increased attention regarding its effects on children with DS [Carter et al., 2008; Freezer et al., 
1995]. Sleep-disordered breathing consists of a continuum of disorders ranging from snoring to 
OSA [Mitchell and Kelly, 2006]. Obstructive sleep apnea is characterized by significant 
obstruction of the upper airway during sleep, resulting in apneic (complete cessation of airflow) 
and hypopneic (significantly reduced airflow) pauses, hypoventilation, hypercarbia, and 
hypoxemia [Iber, 2007]. Polysomnography (PSG) is the standard method for diagnosing OSA 
and requires interpretation by a board certified pediatric sleep specialist [Wise et al., 2011]. 
  Among the general pediatric population, up to 4% of children experience OSA [Beck, 
2009]. Children with DS are at an increased risk for SDB when compared to children without 
DS, with reported prevalence rates of 31% to 75% among various clinic-based samples [Breslin 
et al., 2014; Stores and Stores, 2013], while increased rates among referred samples have been 
documented [Churchill et al., 2012].  The paucity of literature specific to children with DS and 
OSA within narrowed age groups has also been documented [Churchill et al., 2012]. Existing 
studies outlining nocturnal sleep characteristics of children with DS combine data from birth to 
late adolescence and results exclusive to infants are difficult to tease out [Churchill et al., 2012]. 
This gap in research, paired with the 2011 modifications to health screening provisions for 
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children with DS regarding OSA [Bull and The Committee on Genetics, 2011], demonstrates the 
utility of additional research regarding the prevalence of OSA in younger children.  
 Individuals with DS possess phenotypes that may predispose them to SDB including 
adenotonsillar hyperplasia, midfacial and mandibular hypoplasia, hypotonia, small upper airway, 
macroglossia, choanal atresia, and acute cranial base angle [de Miguel-Diez et al., 2003; Ng et 
al., 2006]. Children with DS are more likely to experience sleep abnormalities such as increased 
fragmentation, numerous awakenings and arousals, leg movements, and parasomnias, regardless 
of the presence of OSA [Levanon et al., 1999].  Congenital heart defects are the most prevalent 
congenital condition among children with DS, while GI and oropharyngeal malformations are 
also common [Cleves et al., 2007]. The prevalence of feeding complications among children 
with DS has also been established [Lin et al., 2014]. 
 Longstanding, untreated childhood SDB can be serious, even fatal [Greene and Carroll, 
1997], leading to complications in the cardiovascular, metabolic, and central nervous systems 
[Capdevila et al., 2008; O’Driscoll et al., 2012]. Pulmonary hypertension and cor pulmonale are 
among the most serious consequences of chronic hypoxia and respiratory acidosis from OSA 
[Breslin et al., 2014]. Cognitive development, behavior, daytime function, and quality of life are 
also adversely affected by SDB [Breslin et al., 2014; Mitchell and Kelly, 2006], and have been 
linked specifically to chronic hypoxic exposure [Bass, 2004]. Cognitive impairment associated 
with OSA has been linked to endothelial dysfunction due to hypoxemia, among other factors 
[Lal et al., 2012]. Daytime somnolence is a common result of SDB in adulthood [Katyal et al., 
2013], while attention-deficit hyperactivity disorder  has been  associated with pediatric OSA 
[Huang et al., 2007]. Pediatric SDB has also been linked to sleep deprivation in parents of 
children with DS, resulting in reduced capacity to manage and maintain positive feelings towards 
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children [Carter et al., 2008].  Parents of children with sleep disorders and developmental 
disabilities also report higher levels of maternal stress [Quine, 1991]. 
 Until recently, screening children with DS for OSA before age 5 was uncommon 
[Roizen, 2003]. Current health supervision recommendations for pediatric patients with DS 
suggest discussing symptoms of OSA with parents by the age of 6 months, as well as overnight 
PSG for all children with DS by the age of four, due to the prevalence of SDB in this population 
[Bull and The Committee on Genetics, 2011]. Additionally, Rosen and colleagues [Rosen, 2010] 
propose frequent reassessment of infants with DS and OSA to monitor the necessity of ongoing 
interventions. Alternatives with limited efficacy such as parent questionnaires, audio and 
videotaping, overnight pulse oximetry, and portable monitoring have been used in lieu of 
overnight PSG due to its cost and limited availability. Parent reports have been found to 
underestimate the presence of OSA in children with DS [Lin et al., 2014; Ng et al., 2006; Shott et 
al., 2006], while audio and video taping cannot detect hypopneas or monitor airflow. Further, 
portable monitoring can detect moderate or severe apnea, but lacks utility as a screening device 
[Sinha and Guilleminault, 2010]. The goal of this study is to evaluate clinical correlates of OSA 
among young infants with DS at a specialty clinic. 
MATERIALS AND METHODS 
Participants 
A retrospective review of medical charts was conducted with consent of the IUPUI and 
Clarian Institutional Review Boards. Infants referred to the Down Syndrome Program at Riley 
Hospital for Children were included in the study if they had a diagnosis of DS, were born 
between August 2005 and July 2010 and visited the program between the ages of birth to 6 
months (corrected for prematurity, if indicated).  Karyotypes showed DS was caused by trisomy 
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21 (93%), Robertsonian translocation (4%), mosaic trisomy 21 (1.5%) and unknown (1.5%, 
karyotype results not available, due to having been done at an outside institution).  The Down 
Syndrome Program is a specialty consultation clinic which sees patients from throughout the 
state of Indiana, as well as from bordering regions of neighboring states of Kentucky, Michigan, 
Ohio, and Illinois.  The primary clinic provides comprehensive medical, as well as 
developmental, consultation pertaining to the care of children birth to 21 with DS.  During the 
study period, the clinic was staffed by three Developmental Pediatricians, Pediatric Nurse 
Practitioners, Dietitians, Social Workers and Family Support Staff.  During a portion of the study 
period, a Pediatric Speech-Language Pathologist was also present for consultation.  Physicians 
and Nurse Practitioners participated in medical assessments, including identifying clinical 
concerns regarding airway issues and ordering appropriate evaluations.  
Chart Review 
 The chart review evaluated a wide array of parameters including structural cardiac 
defects, anatomic and functional GI conditions, feeding complications, structural and functional 
airway anomalies, and functional hearing issues. A total of 178 medical charts were reviewed for 
the initial analysis. One chart was eliminated due to insufficient information for this study. Fifty-
nine infants underwent nap (n=55) and/or overnight (n=4) PSG due to symptoms of concern for 
sleep apnea or other airway compromise.  Clinicians at this center considered ordering PSG for 
infants with neck hyperextension with sleep, snoring or noisy breathing with sleep and oxygen 
requirement for unclear indications. Indication for individual studies was not included as part of 
the overall data collection.  Infants who did not complete PSG studies were not considered to 
have OSA (n=109) (see discussion). Nap PSG (≤4 hours in duration) was utilized to screen for 
the presence of OSA in the sample. PSG was performed at Riley Hospital for Children’s Sleep 
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Disorders Center. The eight-room center is based in a quiet, remote location with limited 
windows within the institution. Studies were conducted using the Sandman Elite Version 9.1 
(Embla Systems, Denver, CO, USA) and digitally recorded with the corresponding software 
package. Studies were then manually scored by a physician who was board-certified by the 
American Board of Sleep Medicine using the American Academy of Sleep Medicine (AASM) 
manual [Iber, 2007].  
 Infants were monitored by a respiratory therapist and sleep technician during the studies. 
Parents had the option of attending infants or waiting in nearby rooms. Parameters monitored 
during nap and nocturnal PSG included end-tidal carbon dioxide (CO2), digital pulse oximetry, 
respiratory rates, limb movement, chest and abdominal movement with thoracic and abdominal 
impedance belts, electrocardiogram, electrooculogram to identify rapid-eye movement sleep, 
electromyography to identify chin movement, electroencephalography and oronasal airflow. 
Sleep deprivation and sedation were not used.  
Abnormal breathing was categorized based on the AASM manual [Iber, 2007]. Apneas 
were defined as complete cessation of airflow lasting two breaths, or ten seconds. Hypopneas 
were defined as a marked (50%) reduction in airflow and ≥4% desaturation for a period of two 
breaths, or ten seconds. Apnea-Hypopnea Index (AHI) was defined as the number of apneic plus 
the number of hypopneic events/hour during the study.  Obstructive sleep apnea was defined by 
an AHI of 2 or greater. While the AASM manual defines OSA as AHI greater than or equal to 1, 
we defined obstructive sleep apnea as an AHI of 2 or greater [Iber, 2007]. Mild OSA was defined 
by reports from this lab as AHI between 2 and 5, moderate OSA was defined by AHI between 6 
and 10, and severe OSA was defined by AHI levels of 10 or more. One patient in this study had 
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an AHI that would have required classification as OSA (AHI 1.1) if AASM guidelines had been 
used. No information on central apnea was gathered. 
Analyses 
To identify possible predictors of the presence of OSA among infants with DS, chi-
square tests and binary logistic regression were conducted using the Statistical Package for the 
Social Sciences (SPSS) Version 20.0 for Windows (Chicago, IL, USA). Chi-square tests were 
conducted to determine clinical correlates for OSA among the sample. Regression analysis was 
conducted to determine possible predictors for OSA among the sample. Of the 178 charts 
retrospectively reviewed, one case was omitted from the regression analysis due to insufficient 
information, which left 177 charts fit for analysis. The dependent, dichotomous variable was 
whether or not infants met the criteria for OSA. Predictor variables utilized in the regression 
analysis included gender, the presence of congenital heart disease (CHD), dysphagia, and the 
presence of GI conditions. CHD included atrial septal defects, ventricular septal defects, 
atrioventricular canal defects, tetralogy of Fallot, aortic coarctation, and patent ductus arteriosus. 
Dysphagia was defined as the occurrence of aspiration or significant pharyngeal penetration 
during feeding as identified on videofluoroscopic swallow study. Gastrointestinal conditions 
included duodenal atresia, duodenal stenosis, tracheoesophageal fistula, malrotation, and 
Hirschsprung disease. Gastroesophageal reflux disease (GERD) and constipation were not 
included as GI conditions in the regression analysis to avoid multicollinearity. Factors were 
entered into the analysis using the forward-LR method. Statistical significance was set at P < 
0.05.  
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RESULTS 
 Of the 177 infants with DS seen in the Down Syndrome Program at Riley Hospital for 
Children, 59 (33%) infants underwent nap (n=55) and/or overnight (n=4) PSG due to symptoms 
of concern for sleep apnea or other airway compromise and 56 (95%) were diagnosed with OSA. 
The mean gestational age of all the infants was 37.5 ± 2.1 weeks (median age 38 weeks).  With 
the review, several prominent health diagnoses emerged (Table I). Of the 56 number of patients 
identified as having OSA, 26 (47%) underwent bronchoscopy. Findings on bronchoscopy 
included pharyngomalacia (n=6, 23%), tracheomalacia (n=9, 35%), and laryngomalacia (n=21, 
81%).  Additionally, one patient was identified with unilateral choanal atresia and another patient 
was found to have a tracheal accessory bronchus and paralaryngeal cyst. Chi-square tests 
outlined significant (P<0.05) relationships between OSA and other health conditions (Table I). 
Gender was not found to be significantly related to OSA.    
 Among children who underwent PSG (n=59) the mean age was 44 ± 48 days (Table II). 
Fifty-six infants who completed PSG studies met the criteria for OSA (AHI ≥ 2) (95%). 
Additionally, 71% of infants with OSA met criteria for severe OSA as defined by AHI levels of 
10 or more (n=40) (Figure A). The number of infants with OSA (n=56) compared to infants with 
negative PSG results (n=3) and infants with clinical features that were not indicative of OSA 
(n=109) yielded a prevalence rate of 31% of OSA among the sample from our clinic.  
Additionally, hypercapnia (average EtCO2 mean = 44.6 ± 7.9, range 33-80, n = 51; mean EtCO2 
maximum = 58.5 ± 10.1; range = 44-98, n = 50.) and hypoxemia (average O2 mean = 90.6 ± 
21.8, range 73-95, n = 56; mean O2 minimum = 72.9 ± 26, range = 60-97.8, n =56) were 
observed in the individuals in this study.  
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 Binary logistic regression was conducted to identify the influence of four predictive 
variables (gender, CHD, GI complications, and dysphagia) on the criterion, OSA. Predictive 
variables were determined by analyses conducted prior to regression analysis to avoid 
multicollinearity, and excluded GERD and prematurity as possible predictive variables for the 
regression. The Hosmer-Lemeshow test was not significant at 0.135, which demonstrates the 
goodness-of-fit of our model to the population. The combination of dysphagia and CHD 
predicted the occurrence of OSA in 36% of cases with an overall positive predictive value of 
71% (Wald= 17.19, df=1, P<0.001). Thus, co-occurring dysphagia and CHD were the strongest 
predictors of OSA in this group of infants. Further, odds ratios for correlates of OSA indicate 
that odds of OSA are significantly higher among infants with GI conditions when compared to 
infants without GI conditions (odds ratio, 2.92; 95% confidence interval, 1.75-4.09; P=0.002). 
DISCUSSION 
This study aimed to explore OSA among a sample of young infants with DS at a specialty 
clinic. The average female age at diagnosis was 58 days and was skewed by ten infants in the 
sample that were diagnosed very late (>100 days). Median male age at diagnosis was 20 days. 
Infants with OSA had an average AHI of 19 ± 14, which supports the relationship between 
severe OSA and young age established by de Miguel-Diez and colleagues [de Miguel-Diez et al., 
2003]. However, children younger than one year were not included in the aforementioned study. 
Gender was not predictive of OSA, which aligns with findings reported by Shires and colleagues 
[Shires et al., 2010], yet contradicts other findings [de Miguel-Diez et al., 2003] that  found 
males had higher rates of OSA. Our study indicated that infants with GI issues experienced the 
highest likelihood of also having OSA. The regression model that most accurately predicted the 
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presence of OSA included co-occurring dysphagia and CHD. These findings suggest that infants 
with these comorbidities may warrant increased suspicion and referral for OSA evaluation. 
Our study yielded correlations between OSA and prematurity, CHD, dysphagia, GERD, 
and other GI conditions among infants in our sample. Trisomy affects early development and in a 
mouse model has been linked to deficits in neural crest cells [Roper et al., 2009].  The neural 
crest are cellular precursors and important contributors to many developmental processes 
including to the oropharyngeal, respiratory and gastrointestinal structures.  Additionally, a single 
trisomic gene may affect may affect myriad structures during development [Roper and Reeves, 
2006].  A relationship between the presence and severity of OSA symptoms and GERD has been 
previously reported [Shepherd et al., 2011].  There have been a number of proposed mechanisms 
linking these two conditions including physical, neuromuscular and biochemical factors 
[Wasilewska et al., 2012].  Further, it has been noted that in patients with comorbid GERD and 
OSA, treating OSA with CPAP can reduce nocturnal GERD  [Kerr et al., 1992; Shepherd et al., 
2011; Tawk et al., 2006] and that treating GERD with proton pump inhibitors (PPI) can reduce 
obstructive respiratory events [Wasilewska et al., 2012].  The causal relationship between other 
GI abnormalities and OSA has not been well documented, but may share similar mechanisms to 
those proposed for the relationship between GERD and OSA.  There is, likewise, a paucity of 
information regarding factors that could explain an association between CHD and OSA.  A 
previous study looking at OSA in people with DS ranging in age from 2 weeks to 51 years failed 
to show an association between these factors [Marcus et al. 1991].   
 Outcomes of predictive studies of OSA are varied. Increased levels of severity of OSA 
have been associated with higher body-mass index (BMI) and age levels of children with DS 
[Dyken et al., 2003; Ng et al., 2006; Shires et al., 2010]. Conversely, some studies have not 
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found linear relationships between BMI and severe OSA in pediatric samples without DS 
[Goroza et al., 2009]. Further, young age and male gender have been found to be predictive of 
OSA in one sample of children with DS [de Miguel-Diez et al., 2003]. 
Several limitations to the study exist, and may be taken into consideration to inform 
future research.  First, we assumed that all of the infants who did not have a sleep study (PSG) 
ordered did not have OSA. The prevalence of OSA in our sample was 31% which aligns with 
other studies [Stores and Stores, 2013], but the true prevalence could be much higher as we had a 
limited number of nocturnal PSGs performed among a sample with a high prevalence (95%) of 
OSA among infants who underwent PSG. Second, it was not possible from our dataset to 
determine how many children were referred for PSG, but did not complete the study as 
recommended.  
 Another possible limitation of the study is the use of nap PSG. Nap PSG has been used as 
a screening tool for OSA, but may significantly underestimate prevalence and severity  [Aurora 
et al., 2011]. Additionally, this is a referral population seen at a large tertiary care children’s 
hospital which could increase our estimate due to higher medical complexity of patients referred. 
As such, the results of this study provide information regarding OSA in a specialty clinic, but 
cannot be generalized to the population of patients with DS at large.  The information herein is 
valuable and can be applied to other specialty clinics that see a large number of individuals with 
DS.  Large scale registries of individuals with DS may help to achieve population based studies 
[Oster-Granite et al., 2011]. 
Lastly, the retrospective nature of this study limits follow-up information regarding 
subsequent treatment following the diagnosis of OSA. However, three patients underwent 
tracheostomy, five patients underwent supraglottoplasty, 34 patients required supplemental 
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oxygen at some point during the time studied, and 40 patients utilized an apnea monitor. None of 
the patients in the current study were documented to utilize continuous positive airway pressure 
(CPAP) in the home setting.  The aforementioned limitations may serve as helpful information to 
be considered for future clinical studies.  Additional areas for further study would include the 
natural history of OSA in infants with DS and impact of early identification and treatment on 
future outcomes for these infants.  
 Our findings highlight the increased prevalence and comorbidities of OSA among young 
infants with DS in a specialty clinic. Obstructive sleep apnea may further impact health and 
development of infants with DS. These findings justify further study as well as the evaluation 
procedures and recommended screening for even very young infants with DS. Our findings 
support the AAP 2011 Health Supervision for Children with Down Syndrome recommendations 
to discuss with parents “at least once during the first 6 months of life, the symptoms of 
obstructive sleep apnea, including heavy breathing, snoring, uncommon sleep positions, frequent 
night awakening, daytime sleepiness, apneic pauses, and behavior problems that could be 
associated with poor sleep (and to) refer to a physician with expertise in pediatric sleep disorders 
for examination and further evaluation of a possible sleep disorder if any of the above mentioned 
symptoms occur” [Bull and Committee on Genetics, 2011].  Medical factors including 
prematurity, CHD, GERD, GI conditions, and dysphagia may also help to identify infants who 
are at greater risk for OSA and who may warrant evaluation. 
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Table I. Characteristics of Infants with DS Evaluated for Obstructive Sleep Apnea at the 
Down Syndrome Program at Riley Hospital for Children, August 2005 to December 2011 
 
 
¹ Prematurity in estimated gestational age (weeks) ² Congenital heart disease including atrial septal defects, ventricular septal defects, 
atrioventricular canal defects, tetralogy of Fallot, aortic coarctation, and patent ductus arteriosus ³ Includes the presence of one or more of the following structural or functional gastrointestinal 
abnormalities: gastroesophageal reflux disease, constipation, duodenal atresia, duodenal stenosis, 
tracheoesophageal fistula, malrotation, and Hirschsprung disease. 4 Gastroesophageal reflux disease  
* Denotes statistically significant correlate of obstructive sleep apnea, defined by AHI level of 2 
or greater. 
**Denotes statistical significance of odds ratio P=0.002. 
 
 
 
 Full Sample 
(n=177) 
Infants 
with PSG 
(n=59) 
Infants with 
no identified 
PSG (n=118) 
Mean Estimated Gestational Age 
(weeks) 
37.5 ± 2.1 37 ± 2.4 37.8 ± 1.9 
Male n=93 n=32 n=61 
Female n=84 n=26 n=58 
Prematurity¹* n=37 (21%) n=18 (30%) n=19 (16%) 
CHD2* n=73 (41%) n=30 (50%) n=43 (36%) 
GI Abnormalities3*,** n=102 (57%) n=41 (69%) n=61 (51%) 
GERD4* n=66 (37%) n=29 (49%) n=37 (31%) 
Constipation n=43 (24%) n=21 (36%) n=22 (19%) 
Duodenal Atresia n=10 (5%) n=4 (7%) n=6 (5%) 
Duodenal Stenosis n=3 (1%) n=1 (2%) n=2 (2%) 
Tracheoesophageal Fistula n=0 (0%) n=0 (0%) n=0 (0%) 
Malrotation n=3(1%) n=2 (3%) n=1 (1%) 
Hirschsprung Disease n=12 (7%) n=6 (10%) n=6 (5%) 
Dysphagia* n=89 (50%) n=42 (71%) n=47 (40%) 
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Table II. Polysomnography Results of Infants with Down Syndrome Seen at the Down 
Syndrome Program at Riley Hospital for Children, August 2005 to December 2011 
 
 
 
          
 
 
 
 
 
 
 
 
  
¹ Missing gender for 1 infant that underwent polysomnography. 
 
² Age corrected for prematurity. Average female age at diagnosis skewed by ten infants in 
sample diagnosed very late (>100 days). Median female age at diagnosis was 58 days. Median 
male age at diagnosis was 20 days.  
³Obstructive sleep apnea defined by Apnea Hypopnea Index of 2 or more. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 All Infants 
(n=59)¹ 
Males 
(n=32) 
Females 
(n=26) 
Average age at diagnosis (days)²  44 ± 48 34 ± 37 61 ± 57 
Total sleep time (minutes) 150 ± 69 149 ± 63 151±78 
End-tidal CO2 mean (mm Hg) 44 ± 8 46 ± 9 42 ± 6 
Mean Apnea Hypopnea Index 19 ± 14 20 ±15 19 ±14 
OSA³ Criteria Not Met 3 2 1 
Mild OSA (AHI 2-5) 7 3 4 
Moderate OSA (AHI 6-10) 9 4 5 
Severe OSA (AHI ≥10) 40¹ 22 17 
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Table III. Effects of Dysphagia and Congenital Heart Disease on Obstructive Sleep Apnea1 
among Infants with Down Syndrome Seen at the Down Syndrome Program at Riley 
Hospital for Children, August 2005 to December 2011 
 
 B2 S.E.2 Wald2 df2 Sig.2 Exp(B)2 
Step 13 Dysphagia -1.392 0.349 15.942 1 0.000* 0.249 
Constant -0.112 0.212 0.281 1 0.596 0.894 
Step 24 Congenital Heart Disease5 -0.816 0.350 5.446 1 0.020 0.442 
Dysphagia -1.492 0.360 17.190 1 0.000* 0.225 
Constant 0.390 0.306 1.630 1 0.202 1.477 
 
1 Obstructive sleep apnea defined by Apnea Hypopnea Index of 2 or more. 
 
2 B- regression coefficient for the constant; S.E.- standard error around coefficient for the 
constant; Wald chi-square- tests null hypothesis that the constant equals 0; df- degrees of 
freedom for Wald chi-square test; Sig.- null hypothesis rejected when p-value is <0.001; 
Exp(B)- odds ratio 
 
3 Variable entered in regression analysis on step 1, dysphagia. 
 
4 Variables entered in regression analysis on step 2, dysphagia and congenital heart disease. The 
combination of dysphagia and congenital heart disease demonstrates increased statistical 
significance in regard to the criterion, obstructive sleep apnea. 
 
5 Including atrial septal defects, ventricular septal defects, atrioventricular canal defects, 
tetralogy of Fallot, aortic coarctation, and patent ductus arteriosus.  
 
* Denotes statistical significance. 
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FIGURE LEGEND 
Figure A.  
 
Infants with polysomnography results indicative of obstructive sleep apnea (OSA) (n=56) 
experienced varying degrees of apnea with marked variation occurring beyond the threshold for 
severe OSA (AHI≥10). 
 
 
 
